These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 11384215)

  • 21. Comparative analyses of the 9 glycoprotein genes found in wild-type and vaccine strains of varicella-zoster virus.
    Storlie J; Maresova L; Jackson W; Grose C
    J Infect Dis; 2008 Mar; 197 Suppl 2():S49-53. PubMed ID: 18419408
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Varicella zoster virus: vaccination and implications in children with renal failure.
    Fadrowski JJ; Furth SL
    Expert Rev Vaccines; 2004 Jun; 3(3):291-8. PubMed ID: 15176945
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Ten year follow-up of healthy children who received one or two injections of varicella vaccine.
    Kuter B; Matthews H; Shinefield H; Black S; Dennehy P; Watson B; Reisinger K; Kim LL; Lupinacci L; Hartzel J; Chan I;
    Pediatr Infect Dis J; 2004 Feb; 23(2):132-7. PubMed ID: 14872179
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The effect of vaccination on the epidemiology of varicella zoster virus.
    Edmunds WJ; Brisson M
    J Infect; 2002 May; 44(4):211-9. PubMed ID: 12099726
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Generation of a recombinant Oka varicella vaccine expressing mumps virus hemagglutinin-neuraminidase protein as a polyvalent live vaccine.
    Somboonthum P; Yoshii H; Okamoto S; Koike M; Gomi Y; Uchiyama Y; Takahashi M; Yamanishi K; Mori Y
    Vaccine; 2007 Dec; 25(52):8741-55. PubMed ID: 18053621
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Safety and immunogenicity of live varicella virus vaccine in children with human immunodeficiency virus type 1.
    Armenian SH; Han JY; Dunaway TM; Church JA
    Pediatr Infect Dis J; 2006 Apr; 25(4):368-70. PubMed ID: 16567993
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Vaccine Oka varicella-zoster virus genotypes are monomorphic in single vesicles and polymorphic in respiratory tract secretions.
    Quinlivan MA; Gershon AA; Nichols RA; La Russa P; Steinberg SP; Breuer J
    J Infect Dis; 2006 Apr; 193(7):927-30. PubMed ID: 16518753
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Disseminated varicella infection due to the vaccine strain of varicella-zoster virus, in a patient with a novel deficiency in natural killer T cells.
    Levy O; Orange JS; Hibberd P; Steinberg S; LaRussa P; Weinberg A; Wilson SB; Shaulov A; Fleisher G; Geha RS; Bonilla FA; Exley M
    J Infect Dis; 2003 Oct; 188(7):948-53. PubMed ID: 14513412
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Loss of varicella zoster virus antibodies despite detectable cell mediated immunity after vaccination.
    Ludwig B; Kraus FB; Allwinn R; Keim S; Doerr HW; Buxbaum S
    Infection; 2006 Aug; 34(4):222-6. PubMed ID: 16896582
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Immunity to varicella zoster virus among young adults: a decline prior to widespread uptake of varicella vaccines.
    Grotto I; Balicer RD; Smetana Z; Davidovitch N; Bar-Zeev Y; Mendelson E; Zarka S; Huerta M
    Infection; 2008 Mar; 36(2):130-4. PubMed ID: 18379727
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Molecular analysis of the Oka vaccine strain of varicella-zoster virus.
    Yamanishi K
    J Infect Dis; 2008 Mar; 197 Suppl 2():S45-8. PubMed ID: 18419407
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A role for genetics in the immune response to the varicella vaccine.
    Klein NP; Fireman B; Enright A; Ray P; Black S; Dekker CL;
    Pediatr Infect Dis J; 2007 Apr; 26(4):300-5. PubMed ID: 17414391
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Varicella-vaccine failure in an outbreak in an elementary school in Minnesota.
    Arya SC; Agarwal S; Agarwal N
    J Infect Dis; 2005 Jan; 191(2):318; author reply 318-9. PubMed ID: 15609245
    [No Abstract]   [Full Text] [Related]  

  • 34. Varicella infection caused by Oka strain vaccine in a heart transplant recipient.
    Kraft JN; Shaw JC
    Arch Dermatol; 2006 Jul; 142(7):943-5. PubMed ID: 16847227
    [No Abstract]   [Full Text] [Related]  

  • 35. Varicella vaccination of children in the United States: assessment after the first decade 1995-2005.
    Grose C
    J Clin Virol; 2005 Jun; 33(2):89-95; discussion 96-8. PubMed ID: 15911422
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Analysis of varicella zoster virus attenuation by evaluation of chimeric parent Oka/vaccine Oka recombinant viruses in skin xenografts in the SCIDhu mouse model.
    Zerboni L; Hinchliffe S; Sommer MH; Ito H; Besser J; Stamatis S; Cheng J; Distefano D; Kraiouchkine N; Shaw A; Arvin AM
    Virology; 2005 Feb; 332(1):337-46. PubMed ID: 15661165
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Genotyping of different varicella vaccine strains.
    Sauerbrei A; Zell R; Harder M; Wutzler P
    J Clin Virol; 2006 Oct; 37(2):109-17. PubMed ID: 16905356
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Vaccine effectiveness during a varicella outbreak among schoolchildren: Utah, 2002-2003.
    Haddad MB; Hill MB; Pavia AT; Green CE; Jumaan AO; De AK; Rolfs RT
    Pediatrics; 2005 Jun; 115(6):1488-93. PubMed ID: 15930208
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Molecular studies of Varicella zoster virus.
    Quinlivan M; Breuer J
    Rev Med Virol; 2006; 16(4):225-50. PubMed ID: 16791838
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Humoral and cell-mediated immune responses in children and adults after 1 and 2 doses of varicella vaccine.
    Watson B
    J Infect Dis; 2008 Mar; 197 Suppl 2():S143-6. PubMed ID: 18419388
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.